JPRN-C000000023
Completed
Phase 2
Multicenter phase II trial of neoadjuvant chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma - Phase II trial of neoadjuvant chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma
Chubu research group on oral cancer0 sites30 target enrollmentAugust 1, 2005
Conditionsoral squamous cell carcinoma
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- oral squamous cell carcinoma
- Sponsor
- Chubu research group on oral cancer
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients were excluded if they had active infections, active second malignancy, severe heart diseases, interstitial pneumonia or lung fibrosis, severe pleural effusion or pericardial effusion that required drainage, fever more than or equal to 38 C, symptomatic brain metastasis, severe psychological disease, and possible pregnancy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Multicenter phase II trial of neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin for HER2-positive operable breast cancer: KBOG-1204 trialJPRN-UMIN000010227Kanagawa Breast Oncology Group (KBOG)40
Recruiting
Phase 2
Phase II multicenter trial of neoadjuvant chemotherapy followed by radical hysterectomy and adjuvant chemotherapy by irrinotecan hydrochloride and nedaplatin for the patients with stage Ib2-IIb bulky cervical cancer (tumor diameter > 4 cm): OGSK_KCOG-G1201JPRN-UMIN000008023The Obstetrical and Gynecological Society of Kinki District Japan and the Kansai Clinical Oncology Group68
Not Yet Recruiting
Phase 2
Phase II multicenter study of neoadjuvant chemotherapy with XELOX for locally advanced rectal cancerJPRN-UMIN000024357Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University35
Not Yet Recruiting
Phase 2
Multicenter phase II study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel therapy for patients with resectable pancreatic cancer.Invasive ductal adenocarcinomaJPRN-UMIN000028101Division of Hepato-biliary-pancreatic Surgery Department of Surgery, Kobe University Graduate School of Medicine45
Completed
Phase 2
Phase II trial of neoadjuvant combination chemotherapy with gemcitabine and S-1 for locally advanced pancreatic cancerlocally advanced pancreatic cancerJPRN-UMIN000001450Faculty of Medicine, Kyoto University35